Outcome | Received tocotrienol | Relative risk (95% CI) | Absolute risk reduction (95% CI) | Numbers needed to treat | |
---|---|---|---|---|---|
Yes | No | ||||
n = 120% (Number) | n = 120% (Number) | ||||
Primary end point | |||||
 Breast cancer related death | 0.017 (2) | 0.050 (6) | 0.33 (0.07–1.62) | −0.03 (−0.09 to 0.02) | 30 |
Secondary end point | |||||
 Recurrence | 0.133 (16) | 0.167 (20) | 0.80 (0.44–1.47) | −0.03 (−0.13 to 0.06) | 30 |